A Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil/ Hydrochlorothiazide After a Single Oral Dose Administration Under Fasting Conditions

Condition:   Bioequivalence Interventions:   Drug: Olmesartan Medoxomil/Hydrochlorothiazide 40 Mg/25 Mg film-coated tablets for oral use;   Drug: Olmetec® Plus 40 Mg/25 Mg film-coated tablets for oral use Sponsors:   Pharmtechnology LLC;   Altasciences Company Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials